cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25549/dadrian-ouc113374641
title: Documents (21) on Hovhannes Eskijian

description: 21 documents "originals" on Hovhannes Eskijian: 2-3) "Epilog". Handwritten translation in English by Rose Khrimian (2 pages). 4-7) "Seth's father's biography written by my father (Hovhannes Eskijian]. Copy given to the Bakers." Handwritten in Armenian (4 pages). Dated 1911 [month] 18. 8-10) Letter, to Badvele [Badville]. Handwritten in Armenian (3 pages). 11-13) Our Bi-Monthly Letter: Representing The United Orphanage and Mission Society Operating in Syria, vol. 18, no. 3 (1932 May-June). In English (4 pages). 14) Eula B. Lee (Women's Board of Missions of the Interior), 19 South La Salle Street, Chicago, Illinois, USA, letter, 1920 November 17. "I am glad to state that Mrs. Gulania Eskijian is well known to me..." [sic] -- first line. Handwritten in English (1 page). 15-23) Notes, 1915-1917. Handwritten in Armenian (9 pages). 24-25) Hovhannes Eskijian, letter, 1910 [month] 6, to Gulenia Danielian [Gulenia Eskijian]. Handwritten in Armenian (2 pages) with marginalia in English. 26) Ida Ash, 66 Redcliffe Gardens, Chelsea, England, letter, 1919 December 11, to Gulania Hanum [Gulenia Eskijian]. "How often I have longed to write to all my friends in Aintab..." -- first line. Handwritten in English (1 page). 27-28) Ida Ash, letter, to Gulania [Gulenia Eskijian]. "Badville is the same as you saw him this morning" -- first line. Handwritten in English (2 pages). 29-30) Ida Ash, letter, to Gulania [Gulenia Eskijian]. "I have just asked Miss Breeze about Badville" -- first line. Handwritten in English (2 pages). 31-32) Hovhannes Eskijian. "Էօքսիւզ Զօճուգ Նալէսի" ["More and more"]. Printed in Turkish (Armenian script) (2 pages). 33) Ida Ash, the hospital, letter, 1916 March, to Gulania [Gulenia Eskijian]. "I am so very sorry to hear that Badville is ill..." -- first line. Handwritten in English (1 page). 34-35) Letter, 1916. Handwritten in Armenian (2 pages). 36) Letter, 1916 [month] 1. Handwritten in Armenian (1 page). 37-45) "Testimonial by Rev. Hadidian" -- label. Handwritten in Armenian (7 pages), 1921 [month] 18. With envelope, 1921 May 19, to Gulenia H. Eskijian, 1726 Inskip Street, Pasadena, California, USA. (2 pages). 46-47) Letter, 1916 [month] 26. Handwritten in Armenian (2 pages). 48-50) E.E. Elmajian (care of Naomi Elmadjian), Rue Khalil Badawi, Beirut, Lebanon, letter, 1960 March 8, to Luther Eskijian, 2223 Midlothian Drive, Altadena, California, USA. "Grace and peace to you and to your dear family..." -- first line. Handwritten in English (2 pages). With envelope (1 page). 51-56) Naomi Elmadjian and Miriam Demirjian. "How have I know Rev. John Eskijian" [sic], 1960 March 1. Handwritten testimonial in English (2 copies each 3 pages). 57-63) E.E. Elmajian. "Testimonial by Rev. E. Elmajian about Rev. H. Eskijian". Typewritten in English (7 pages). 64-68) E.E. Elmajian. "Rev Hovhannes Eskijian: how I know him", 1978 July 31. Handwritten in English in the hand of Gulenia Esjijian (5 pages). 69-74) Friend of Ed. Tovmassian's sister, letter, 1976 February 20, to Ed. Tovmassian's sister. Handwritten in Armenian (6 pages).
DOI: 10.6084/m9.figshare.31436152
title: Supplementary Material for: Nitrous Oxide Induced Subacute Degeneration of the Spinal Cord Requiring Spinal Rehabilitation: A Case Report

description: Background: Nitrous oxide is a widely available anaesthetic agent whose chronic use causes irreversible inactivation of vitamin B12, leading to subacute combined degeneration of the spinal cord (SACD). While high‑dose intramuscular B12 replacement often halts disease progression, complete neurological recovery is not always achieved.

Case presentation: A 19‑year‑old Chinese male with a three month history of nitrous oxide use presented to the emergency department with acute lower‑limb weakness and encephalopathy. Examination revealed mild upper‑limb paresis, diminished deep tendon reflexes, and minimal voluntary movement in the legs. Laboratory studies showed pancytopenia, undetectable serum vitamin B12, and markedly elevated homocysteine. MRI of the brain and spine demonstrated generalised cerebral atrophy with white‑matter foci and extensive hyperintensity throughout the upper spinal cord.

Complications included bilateral pulmonary emboli and lower‑limb deep venous thrombosis, managed initially with intravenous heparin followed by enoxaparin and a 6‑month course of apixaban. The patient received high‑dose intramuscular B12, oral methionine, thiamine, and supportive care for skin lesions. After a period of intense multidisciplinary rehabilitation, functional independence was restored although not complete neurological recovery.

Conclusion: This case illustrates that nitrous oxide–induced SACD can present with profound neurological dysfunction but responds favourably to prompt vitamin B12 replacement, combined with multidisciplinary rehabilitation.
DOI: 10.6084/m9.figshare.31436152.v1
title: Supplementary Material for: Nitrous Oxide Induced Subacute Degeneration of the Spinal Cord Requiring Spinal Rehabilitation: A Case Report

description: Background: Nitrous oxide is a widely available anaesthetic agent whose chronic use causes irreversible inactivation of vitamin B12, leading to subacute combined degeneration of the spinal cord (SACD). While high‑dose intramuscular B12 replacement often halts disease progression, complete neurological recovery is not always achieved.

Case presentation: A 19‑year‑old Chinese male with a three month history of nitrous oxide use presented to the emergency department with acute lower‑limb weakness and encephalopathy. Examination revealed mild upper‑limb paresis, diminished deep tendon reflexes, and minimal voluntary movement in the legs. Laboratory studies showed pancytopenia, undetectable serum vitamin B12, and markedly elevated homocysteine. MRI of the brain and spine demonstrated generalised cerebral atrophy with white‑matter foci and extensive hyperintensity throughout the upper spinal cord.

Complications included bilateral pulmonary emboli and lower‑limb deep venous thrombosis, managed initially with intravenous heparin followed by enoxaparin and a 6‑month course of apixaban. The patient received high‑dose intramuscular B12, oral methionine, thiamine, and supportive care for skin lesions. After a period of intense multidisciplinary rehabilitation, functional independence was restored although not complete neurological recovery.

Conclusion: This case illustrates that nitrous oxide–induced SACD can present with profound neurological dysfunction but responds favourably to prompt vitamin B12 replacement, combined with multidisciplinary rehabilitation.
DOI: 10.25549/dadrian-ouc113374649
title: Friend of Ed. Tovmassian's sister, letter, 1976-02-20, to Ed. Tovmassian's sister [label]

description: Friend of Ed. Tovmassian's sister, letter, 1976 February 20, to Ed. Tovmassian's sister. Handwritten in Armenian (6 pages).
DOI: 10.25549/dadrian-ouc113707788
title: Hovhannes & John Eskijian with an unidentified boy, Ekiz-Oluk, near Kessal, Syria, 1913-1914

description: Photograph of Hovhannes Eskijian (rear) and his son John Emanuel Eskijian (sitting) with an unidentified boy, Ekiz-Oluk, near Kessal, Syria, 1913-1914. 2 copies.
DOI: 10.25549/satjrnl-m636
title: Zritel', vol. 1, no. 16 (1905)

description: [description (english with transliteration)] Zritel' [Spectator], no.16, September 25, 1905. Weekly. Published and edited by Iu. K. Artsybushev. St. Petersburg. Typography: "Sever" of A. M. Lesman. Journal of political-social satire -- Rudzinskii, no. 53; BPIR, no. 3230.; Editors: Iu. K. Artsybushev, G. E. Gints, I. Ia. Kagan, N. I. Faleev. Contributors: Azra (A. B. Zengera), L. I. Andruson, B. B. Bashkin, Il. B. Gurevich, L. M. Evreinov, V. D. Zamirailo, A. A. Kudinov, B. S. Likhachev, Mstislava, S. I. Polferov, A. S. Roclavlev, V. A. Stolovich, B. G. Uspenskago, N. G. Shauman, N. I. Shestopalov.
DOI: 10.6084/m9.figshare.31436155
title: Supplementary Material for: Prediction model of malignant risk of gastrointestinal stromal tumor based on endoscopic ultrasonography

description: Introduction: Gastrointestinal stromal tumors (GIST) are clinically heterogeneous mesenchymal tumors, and accurate assessment of their malignancy is crucial for determining treatment strategies and predicting patient prognosis. This study aims to establish and validate a preoperative prediction model for the malignant risk of GIST based on endoscopic ultrasound (EUS) findings.
Methods: In this retrospective study, we collected data from patients with GIST at Sichuan Provincial People's Hospital. Statistical analyses involved univariate and multivariate logistic regression models, with Firth's bias reduction penalty likelihood logistic regression employed to address data separation and multicollinearity. Model discrimination was assessed using AUC, and the Bootstrap ROC method was used for validation. Finally, a nomogram was constructed to visually represent the predictive model.
Results: In this study, we analyzed 500 patients with GIST, including low (n=393) and high-risk groups (n=107). Univariate and multivariate logistic regression analyses revealed hard elastography and contrast-enhanced EUS (CE-EUS) of visible tumor vessels as potent independent risk factors associated with GIST malignancy, Firth's bias reduction penalty likelihood logistic regression confirmed hard elastography (OR=146.222, 95%CI: 12.597-1017.552) and CE-EUS with visible tumor vessels (OR=402.853, 95%CI: 12.732-7633.787) as significant predictors. Finally, we identified five optimal predictors (including size, shape, echogenicity, elastography, and visible tumor vessels). The predictive model demonstrated exceptional accuracy with an AUC of 0.9998, further validated by Bootstrap ROC analysis showing an AUC of 1. 
Conclusion: A nomogram incorporating tumor size, shape, echogenicity, elastography, and visible tumor vessels was developed. However, because internal validation indicated overfitting, the model’s clinical utility requires rigorous external validation.
DOI: 10.6084/m9.figshare.31436155.v1
title: Supplementary Material for: Prediction model of malignant risk of gastrointestinal stromal tumor based on endoscopic ultrasonography

description: Introduction: Gastrointestinal stromal tumors (GIST) are clinically heterogeneous mesenchymal tumors, and accurate assessment of their malignancy is crucial for determining treatment strategies and predicting patient prognosis. This study aims to establish and validate a preoperative prediction model for the malignant risk of GIST based on endoscopic ultrasound (EUS) findings.
Methods: In this retrospective study, we collected data from patients with GIST at Sichuan Provincial People's Hospital. Statistical analyses involved univariate and multivariate logistic regression models, with Firth's bias reduction penalty likelihood logistic regression employed to address data separation and multicollinearity. Model discrimination was assessed using AUC, and the Bootstrap ROC method was used for validation. Finally, a nomogram was constructed to visually represent the predictive model.
Results: In this study, we analyzed 500 patients with GIST, including low (n=393) and high-risk groups (n=107). Univariate and multivariate logistic regression analyses revealed hard elastography and contrast-enhanced EUS (CE-EUS) of visible tumor vessels as potent independent risk factors associated with GIST malignancy, Firth's bias reduction penalty likelihood logistic regression confirmed hard elastography (OR=146.222, 95%CI: 12.597-1017.552) and CE-EUS with visible tumor vessels (OR=402.853, 95%CI: 12.732-7633.787) as significant predictors. Finally, we identified five optimal predictors (including size, shape, echogenicity, elastography, and visible tumor vessels). The predictive model demonstrated exceptional accuracy with an AUC of 0.9998, further validated by Bootstrap ROC analysis showing an AUC of 1. 
Conclusion: A nomogram incorporating tumor size, shape, echogenicity, elastography, and visible tumor vessels was developed. However, because internal validation indicated overfitting, the model’s clinical utility requires rigorous external validation.
DOI: 10.6084/m9.figshare.31436161
title: Supplementary Material for: Ageing, Wealth, and Diet: A Global Cross-National Analysis of Cereal Consumption and Dementia Risk

description: Background:
Global variation in dementia incidence reflects demographic and socioeconomic forces, yet the role of staple dietary patterns remains less defined. While population ageing is a key determinant of dementia burden, differences in cereal consumption, particularly rice, wheat, and maize, have received limited attention. This ecological study examined whether national cereal consumption patterns are associated with dementia incidence across countries independent of confounding factors. 
Methods:
Country level data from 204 nations were compiled, with complete case analyses conducted in 184 countries. Alzheimer’s disease and other dementias incidence in 2021 served as the outcome variable. Predictors included per capita consumptions of total cereals, rice, wheat, and maize, alongside genetic predisposition, economic affluence, urban living, ageing indexed by life expectancy at age sixty, and meat consumption. Pearson and partial correlations, principal component analysis, and stepwise multiple regression were applied. 
Results:
Wheat consumption was positively associated with dementia incidence, affluence, and longevity, whereas rice and maize consumption showed inverse associations. Partial correlations confirmed a persistent inverse association for rice consumption and a weaker inverse association for total cereal consumption after adjustment. Principal component analysis identified a socioeconomic component aligned with wheat consumption and ageing, while rice and maize loaded inversely. Stepwise regression demonstrated that ageing was the strongest predictor of dementia incidence, while rice and total cereal consumption retained small independent inverse associations. 
Conclusions:
Global dementia incidence is driven primarily by population ageing and socioeconomic development. Cereal type reflects distinct developmental contexts, with rice-based patterns associated with a modestly lower dementia burden.
DOI: 10.6084/m9.figshare.31436161.v1
title: Supplementary Material for: Ageing, Wealth, and Diet: A Global Cross-National Analysis of Cereal Consumption and Dementia Risk

description: Background:
Global variation in dementia incidence reflects demographic and socioeconomic forces, yet the role of staple dietary patterns remains less defined. While population ageing is a key determinant of dementia burden, differences in cereal consumption, particularly rice, wheat, and maize, have received limited attention. This ecological study examined whether national cereal consumption patterns are associated with dementia incidence across countries independent of confounding factors. 
Methods:
Country level data from 204 nations were compiled, with complete case analyses conducted in 184 countries. Alzheimer’s disease and other dementias incidence in 2021 served as the outcome variable. Predictors included per capita consumptions of total cereals, rice, wheat, and maize, alongside genetic predisposition, economic affluence, urban living, ageing indexed by life expectancy at age sixty, and meat consumption. Pearson and partial correlations, principal component analysis, and stepwise multiple regression were applied. 
Results:
Wheat consumption was positively associated with dementia incidence, affluence, and longevity, whereas rice and maize consumption showed inverse associations. Partial correlations confirmed a persistent inverse association for rice consumption and a weaker inverse association for total cereal consumption after adjustment. Principal component analysis identified a socioeconomic component aligned with wheat consumption and ageing, while rice and maize loaded inversely. Stepwise regression demonstrated that ageing was the strongest predictor of dementia incidence, while rice and total cereal consumption retained small independent inverse associations. 
Conclusions:
Global dementia incidence is driven primarily by population ageing and socioeconomic development. Cereal type reflects distinct developmental contexts, with rice-based patterns associated with a modestly lower dementia burden.
DOI: 10.6084/m9.figshare.31436164
title: Supplementary Material for: The Impact of Type 2 Diabetes Mellitus on Hepatic Fibrosis in Patients with metabolic dysfunction-associated steatotic liver disease – a cross-sectional study

description: Aims: Evaluate the impact of type 2 diabetes on hepatic fibrosis in patients with MASLD. 
Materials and Methods: This cross-sectional study used retrospective data from patients with MASLD who underwent liver elastography between July 2022 and February 2024. Controlled Attenuation Parameter (CAP) ≥ 248 dB/m was considered diagnostic for steatosis; elasticity (kPa) of 8.7-10.2 kPa for F3 and &gt;10.2 kPa for F4. Clinical, demographic, and laboratory data were collected. Other etiologies of liver disease were excluded. Patients were divided into Group 1 (with diabetes) and Group 2 (without diabetes). 
Results: A total of 252 individuals were included, 96 in Group 1 and 156 in Group 2. The mean age was 56 years, and the median body mass index (BMI) was 31.0 kg/m².There was a positive correlation between the degree of steatosis and the stage of fibrosis (p &lt; 0.01). The prevalence of steatosis S3 was 83.3% in Group 1 versus 70.5% in Group 2 (p=0.022). Fibrosis F3/F4 was present in 45.8% of Group 1 compared to 12.2% of Group 2 (p&lt;0.001), while presumed cirrhosis affected 33.3% of Group 1 and 6.4% of Group 2 (p &lt; 0,001).
Conclusions: Type 2 diabetes was associated with a higher degree of steatosis and more severe hepatic fibrosis in patients with MASLD, with presumed cirrhosis present in about one-third of patients with diabetes. Early diagnosis of MASLD in type 2 diabetes and screening for complications (cirrhosis and hepatocellular carcinoma) should be implemented.
DOI: 10.6084/m9.figshare.31436164.v1
title: Supplementary Material for: The Impact of Type 2 Diabetes Mellitus on Hepatic Fibrosis in Patients with metabolic dysfunction-associated steatotic liver disease – a cross-sectional study

description: Aims: Evaluate the impact of type 2 diabetes on hepatic fibrosis in patients with MASLD. 
Materials and Methods: This cross-sectional study used retrospective data from patients with MASLD who underwent liver elastography between July 2022 and February 2024. Controlled Attenuation Parameter (CAP) ≥ 248 dB/m was considered diagnostic for steatosis; elasticity (kPa) of 8.7-10.2 kPa for F3 and &gt;10.2 kPa for F4. Clinical, demographic, and laboratory data were collected. Other etiologies of liver disease were excluded. Patients were divided into Group 1 (with diabetes) and Group 2 (without diabetes). 
Results: A total of 252 individuals were included, 96 in Group 1 and 156 in Group 2. The mean age was 56 years, and the median body mass index (BMI) was 31.0 kg/m².There was a positive correlation between the degree of steatosis and the stage of fibrosis (p &lt; 0.01). The prevalence of steatosis S3 was 83.3% in Group 1 versus 70.5% in Group 2 (p=0.022). Fibrosis F3/F4 was present in 45.8% of Group 1 compared to 12.2% of Group 2 (p&lt;0.001), while presumed cirrhosis affected 33.3% of Group 1 and 6.4% of Group 2 (p &lt; 0,001).
Conclusions: Type 2 diabetes was associated with a higher degree of steatosis and more severe hepatic fibrosis in patients with MASLD, with presumed cirrhosis present in about one-third of patients with diabetes. Early diagnosis of MASLD in type 2 diabetes and screening for complications (cirrhosis and hepatocellular carcinoma) should be implemented.
DOI: 10.6084/m9.figshare.31436167
title: Supplementary Material for: Respiratory and Cardiovascular Readmissions and Prescription Patterns After Spinal Cord Injury: A National Registry-Based Study from Sweden

description: Introduction: 
Spinal cord injury (SCI) is associated with increased risk of cardiovascular and respiratory morbidity, which are major contributors to rehospitalization and mortality. While overall rehospitalization after SCI is well documented, few studies have focused specifically on early cardiopulmonary readmissions or linked these outcomes with prescription patterns using nationwide registry data. 
Methods: 
We linked the Swedish SCI register (SveReh) to the National Patient Register and Prescribed Drug Register. Adults with new-onset SCI admitted for first-time inpatient rehabilitation between 2016 and 2020 were included (n = 1,196). The cohort was followed for 12 months after discharge. Outcomes were cardiovascular (ICD I) and respiratory (ICD J) readmissions. Kaplan–Meier and Cox regression analyses examined predictors (age, neurological level, pre-SCI drug use). Prescription changes for cardiovascular drugs (ATC C), respiratory drugs (ATC R), and antibiotics (ATC J01) were analyzed 365 days before and after SCI using McNemar’s test. 
Results: 
Within 12 months, 42 persons (3.5%) were readmitted for cardiovascular and 43 (3.6%) for respiratory causes; &gt;96% remained event-free. Older age predicted both cardiovascular (HR 1.02 per year, 95% CI 1.00–1.05, p = 0.050) and respiratory readmissions (HR 1.02, 95% CI 1.00–1.04, p = 0.024). Neurological level was also associated with respiratory readmission, with highest risk in C1–C4 tetraplegia. Prescription analyses (n = 1173) showed significant increases in antibiotics (+27.7%), cardiovascular drugs (+7.2%), and respiratory drugs (+3.4%). 
Conclusion: 
Cardiovascular and respiratory readmissions within one year after SCI were uncommon but strongly influenced by age, and for respiratory causes, by neurological level. Marked increases in antibiotic prescriptions highlight infection burden, while cardiovascular prescribing reflected age-related comorbidity. These findings identify subgroups who may benefit from targeted preventive follow-up.